# Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy

Study · id `cardio:ct-nct03700801` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03700801](<https://clinicaltrials.gov/study/NCT03700801>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03700801

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

## Technical summary

Registry record NCT03700801. Non-randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2019-12-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT03700801, source copy `cardio:ctgov-nct03700801-2024-03-18`, retrieved 2026-10-26)
- Started: 2018-10-01 (actual) (ClinicalTrials.gov record NCT03700801, source copy `cardio:ctgov-nct03700801-2024-03-18`, retrieved 2026-10-26)
- Primary completion: 2019-12-20 (actual) (ClinicalTrials.gov record NCT03700801, source copy `cardio:ctgov-nct03700801-2024-03-18`, retrieved 2026-10-26)
- Completion: 2019-12-20 (actual) (ClinicalTrials.gov record NCT03700801, source copy `cardio:ctgov-nct03700801-2024-03-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03700801, source copy `cardio:ctgov-nct03700801-2024-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03700801-2024-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Triple combination therapy group
- Intervention (Drug): Premixed insulin therapy group
- Lead sponsor: Zhujiang Hospital
- Lead sponsor class: OTHER
- Collaborator: The Sixth Affiliated Hospital of Guangzhou Medical University
- Collaborator class: OTHER
- Collaborator: Third Affiliated Hospital, Sun Yat-Sen University
- Collaborator class: OTHER
- Collaborator: Peking University Shenzhen Hospital
- Collaborator class: OTHER
- Collaborator: Dongguan Kanghua Hospital
- Collaborator class: OTHER
- Collaborator: First People's Hospital, Shunde China
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Guangdong Pharmaceutical University
- Collaborator class: OTHER
- Collaborator: The Fifth Affiliated Hospital of Zunyi Medical College
- Collaborator class: OTHER
- Collaborator: Shenzhen Sixth People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Zhujiang Hospital (`cardio:org-zhujiang-hospital`)
- Registry lists this organization as a collaborator: Third Affiliated Hospital, Sun Yat-Sen University (`cardio:org-third-affiliated-hospital-sun-yat-sen-university`)
- Registry lists this organization as a collaborator: Peking University Shenzhen Hospital (`cardio:org-peking-university-shenzhen-hospital`)

## Provenance

Content hash: c50ae1c6220dac82bfd4c69e6660cb773af0d8964a5e71beb4dfa079992900b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
